Sijunzi Decoction attenuates 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats and ameliorates TNBS-induced claudin-2 damage via NF-κB pathway in Caco2 cells
Authors:
Open Access
- 10 January 2017
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 17 (1) , 1-13
Abstract
SijunziDecoction (SJZD) is a traditional Chinese medicine prescription used to treat the diseases of gastrointestinal tract since ancient times. The objective of this study was to investigate the protective effects of SJZD on TNBS-induced colitis in rats and TNBS-damaged Caco2 cells. The rat colitis model was induced by 2, 4, 6-trinitrobenzene sulfonic acid (TNBS). SJZD (2.8 5.6, 11.2 g/kg) or salazosulfapyridine (SASP) (0.4 g/kg) was administrated orally in rats for 7 days. DAI, pathological scores and the expression of claudin-2 were evaluated. Then we explored the effect and mechanism of SijunziDecoction Serum (SJZDS) onTNBS-damaged Caco2 cells to figure out intestinal barrier protective effect and mechanism of SJZD. SJZD significantly ameliorated the severity of TNBS-induced colitis and downregulated the level of claudin-2 in colonic tissues. SJZDS promoted proliferation and inhibited apoptosis ofTNBS-damaged Caco2 cells. In Caco2 cell monolayers, we provided mechanistic evidence that SJZDS-induced increased TEER and decreased permeability after TNBS damage, which were mediated through claudin-2 and NF-κB pathway, including the upregulation of claudin-2, decreased activity of NF-κB p65, reduced level of NF-κB p65 and MLCK. Our results indicated that SJZD possesses protective effect of intestinal barrier towards TNBS-induced colitis in rats and TNBS-damaged Caco2 cells in vitro. SJZDis a potential protective agent of intestinal barrier that deserves further investigation.Keywords
Funding Information
- Natural Science Foundation of China (81202635)
- Foundation of Guangdong Provincial Bureau of Chinese Medicine (20151244)
This publication has 36 references indexed in Scilit:
- Active components alignment of Gegenqinlian decoction protects ulcerative colitis by attenuating inflammatory and oxidative stressJournal of Ethnopharmacology, 2015
- Claudin-2 Regulates Colorectal Inflammation via Myosin Light Chain Kinase-Dependent SignalingDigestive Diseases and Sciences, 2013
- Treatment of inflammatory bowel disease (IBD)Pharmacological Reports, 2011
- Role of p38 MAPK in Burn-Induced Intestinal Barrier BreakdownJournal of Surgical Research, 2009
- Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2008
- Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel diseaseLaboratory Investigation, 2006
- Endothelial cell myosin light chain kinase (MLCK) regulates TNF?-induced NF?B activityJournal of Cellular Biochemistry, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cellsProceedings of the National Academy of Sciences, 2001